Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients
NCT03401268
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hypogammaglobulinemia
Interventions
DRUG:
subcutaneous immunoglobulin
Sponsor
University Health Network, Toronto
Collaborators
[object Object]